Clinical Trials Browser

Phase 2 × Colorectal Cancer Liver Metastases × regorafenib × Clear all

NCT05485909 2022-08-03

Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM

Phase 2 Unknown

Gastrointestinal

Colorectal Cancer Liver Metastases